Pentwater Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$311K	–	116
2019 Q3	$311K	Buy	+20,000	New	+$311K	﹤0.01%	97